Legal Representation
Attorney
David L. May
USPTO Deadlines
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 1, 2016 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Feb 1, 2016 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Jul 9, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 8, 2015 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jun 23, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 23, 2015 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Dec 16, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Dec 15, 2014 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Dec 11, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 11, 2014 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jun 3, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 2, 2014 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
May 28, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 28, 2014 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jan 31, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 30, 2014 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 24, 2014 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jan 24, 2014 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Dec 4, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 4, 2013 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jun 20, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 18, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 18, 2013 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jun 18, 2013 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Dec 25, 2012 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 30, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 30, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 10, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 21, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Sep 20, 2012 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Sep 20, 2012 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 20, 2012 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 20, 2012 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Sep 20, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 7, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 7, 2012 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Sep 7, 2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 4, 2012 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
Aug 26, 2012 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
Aug 10, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
Aug 10, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Jul 27, 2012 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jul 27, 2012 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 27, 2012 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 27, 2012 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jul 27, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jul 20, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 19, 2012 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 19, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 14, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Detailed Classifications
Class 001
Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting cellular activity or gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in modifying and regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; antibodies for scientific and research use; antibodies for regulating, modifying or regulating cellular functions in plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting cellular activity or gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Chemical preparations for medical and veterinary purposes, namely, chemical preparations for regulating, modifying, or restricting cellular activity or gene expression for purposes of treating diseases and genetic disorders; chemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for antibody therapy analysis; Pharmaceutical preparations for modifying or regulating one or more cellular functions of mammals, fungi, plants, and bacteria and transgenic mammals, fungi, plants, and bacteria; transgenic plants, fungi and bacteria for medical and veterinary purposes; antibodies for use in disease testing; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Custom manufacturing and custom synthesis of antibodies and genetically engineered DNA expressing antibodies, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Development of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being antibodies and genetic therapies expressing antibodies to regulate, modulate, treat, prevent, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and antibody technology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells expressing antibodies for scientific, research, medical, veterinary and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Antibody technology and gene therapy services for others for product development and scientific research purposes, namely, antibody production, genetically engineering DNA expressing antibodies, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services; Medical services, namely, antibody and gene therapy services; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere:
0
First Use in Commerce:
0
Class 045
Technology transfer services, namely, licensing and transfer of intellectual property; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
040
042
044
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MAB"